Strategies of genome editing in mycobacteria: Achievements and challenges
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 98, 132-138
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, India (BT/PR8616/MED/29/793/2013)
This publication has 61 references indexed in Scilit:
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteriaProceedings of the National Academy of Sciences, 2012
- Evolution and classification of the CRISPR–Cas systemsNature Reviews Microbiology, 2011
- Interaction of the Cas6 Riboendonuclease with CRISPR RNAs: Recognition and CleavageStructure, 2011
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcriptionNature Biotechnology, 2011
- CRISPR interference: RNA-directed adaptive immunity in bacteria and archaeaNature Reviews Genetics, 2010
- Regulatory RNAs in BacteriaCell, 2009
- In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in miceNature Medicine, 2007
- Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2007
- RNA interferenceNature, 2002